Walleye Capital LLC Gritstone Bio, Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.28 - $2.85 $15,360 - $34,200	12,000 New	12,000 $24,000
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $563,059 - $706,421	-69,257 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $152,344 - $1.01 Million	-37,431 Reduced 35.08%	69,257 $653,000
Q4 2020 Feb 16, 2021	SELL	$2.57 - $4.22 $168,052 - $275,945	-65,390 Reduced 38.0%	106,688 $420,000
Q3 2020 Nov 16, 2020	BUY	$2.63 - $8.09 $452,565 - $1.39 Million	172,078 New	172,078 $456,000
Q1 2019 May 15, 2019	SELL	$9.97 - $18.96 $4,715 - $8,968	-473 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $6,735 - $6,735	473 New	473 $7,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.